Creative campaigns to raise awareness of an incredible milestone in modern HIV treatment and the danger of a second heart attack has helped a global communications agency achieve its best ever year at the PM Society Awards.
Havas Lynx Group, which comprises Havax Lynx, Union, Faze and H4B, secured a record-breaking nine Gold Awards at the prestigious ceremony held at the Grosvenor Hotel in London.
The Gold Awards were for six cutting-edge campaigns for a host of global clients, including ViiV, Sanofi Genzyme and Regeneron, Teva and Astra Zeneca.
These were followed up by further recognition, with the agency also securing a further 11 Silver and Bronze titles covering Disease Awareness (Patients), Corporate Communications and Events and Exhibitions.
“Last year, we were recognised in eleven different categories so to almost double that in 2019, especially when you consider the scale of competition and standing of the PM Society Awards,” explained Tom Richards, Chief Creative Officer of Havas Lynx Group.
“It really shows the important role creativity has to play within pharma and health communications and how a strong creative idea has the potential to drive that all important messaging to make a difference to the lives of patients. It’s a really exciting time to be a creative working in pharma.”
